Medical and Health

Porcine Vaccines Market Insights, Trends, Growth, Outlook and Analysis 2018-2026


Porcine-Vaccine362.jpg

 1 Views

 

Vaccines are the most imperative mediations for disease control among animals and humans. Under veterinary pharmaceuticals, vaccination is considered as a windfall for maintaining animal health by preventing spread of several endemic diseases. Such diseases which can be endemic are porcine reproductive and respiratory virus (PRRSV), swine influenza, diarrhea, porcine circovirus associated disease (PCVAD). Furthermore, cholera, high fever, foot and mouth diseases in swine have been significantly eliminated in North America through immunization.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1685

Some commercially available (non-autogenous) porcine reproductive and respiratory syndrome (PRRS) vaccines are:

Current Name

Type

Virus Strain Origin

Manufacturer

Amervac-PRRS

Attenuated

European

Hipra Laboratorios

Suvaxyn-PRRS2

Inactivated

European

Fort Dodge Veterinaria SA

Ingelvac PRRS MLV3

Attenuated

North American

Boehringer Ingelheim

Ingelvac PRRS ATP

Attenuated

North American

Boehringer Ingelheim

Porcilis PRRS

Attenuated

European

Intervet

Progressis

Inactivated

European

Merial

PRRomiSe

Inactivated

North American

Intervet

Pyrsvac-183

Attenuated

European

Laboratories Syva

Suipravac- PRRS

Inactivated

European

Hipra Laboratories

Source: Journal of Swine Health and Production

Porcine Vaccines Market – Driver

Increasing demand for gelatin is projected to support the growth of the market, as porcine gelatin is used as a stabilizer to ensure safety and efficacy of vaccine during storage. Furthermore, rising demand for meat, milk, eggs, & animal protein and concerns regarding the increasing incidences of zoonotic diseases are expected to propel the growth of the porcine vaccines market during the forecast period. For instance, Vietnam is the third country in the world by per-capita pig meat consumption, with an average of 29.14 kilos of meat consumed in 2015.

Request TOC of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1685

Researchers are also engaged in developing vaccines for major disease such as African swine flu (ASF), which is augmenting growth of the market. This disease is present in sub-Saharan Africa, Sardinia, the Russian Federation, and number of Eastern European countries. To date, there is no vaccine for this economically devastating disease however, in 2017, Researchers in Australia and the U.S. uncovered genetic data that may help in developing a vaccine for African swine fever, in turn boosting growth of the porcine vaccines in near future. However, the high cost of maintaining, handling, and storage of vaccines is one of the major factor restraining growth of the porcine vaccine market to some extent.

Porcine Vaccines Market - Regional Analysis

On the basis of geography, the global porcine vaccines market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the largest market share in the global porcine vaccines market, attributable to highly organized farming structure, increased demand for animal protein, and rising expenditure on animal health by farm owners. Moreover, export and import permits among contract manufacturers or distributer firms and low estimated cost of products are expected to make the porcine vaccine market more popular in Europe. For instance, in 2016, a UK-based Cranswick Foods company initiated a project to set up pork processing plant in Punjab, which would act as a catalyst to hasten the process of value addition in animal husbandry sector and give boost to the farm diversification, providing high quality pork to the consumers across the state. The market in Asia Pacific (including Vietnam, the Philippines, etc.) is estimated to grow at a significant CAGR during the forecast period as this countries have large consumption of pig meat, which in turn is fostering growth of the market.

Porcine Vaccines Market – Competitive Landscape

Key players are introducing porcine vaccines with new features such as such as DNA vaccines, recombinant vaccines, and conjugate vaccines. This advanced vaccines are expected to improve the efficiency and effectively of swine production practices with reduction in overall vaccination cost.

Major players operating in porcine vaccines market include Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A, and Vetoquinol, Zoetis, Inc.

Click To Continue Reading On Porcine Vaccines Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Visit our news Website: https://www.coherenttimes.org





Coherent Market Insights

Abhijit R

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.